BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17628913)

  • 1. Congenital adrenal hyperplasia clinical characteristics and genotype in newborn, childhood and adolescence.
    Pasqualini T; Alonso G; Tomasini R; Galich AM; Buzzalino N; Fernandez C; Minutolo C; Alba L; Dain L
    Medicina (B Aires); 2007; 67(3):253-61. PubMed ID: 17628913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
    de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
    Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia.
    Torres N; Mello MP; Germano CM; Elias LL; Moreira AC; Castro M
    Braz J Med Biol Res; 2003 Oct; 36(10):1311-8. PubMed ID: 14502362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.
    Livadas S; Dracopoulou M; Dastamani A; Sertedaki A; Maniati-Christidi M; Magiakou AM; Kanaka-Gantenbein C; Chrousos GP; Dacou-Voutetakis C
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):543-9. PubMed ID: 25041270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
    Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution of intrafamilial CYP21A2 mutant alleles and investigation of clinical features in Turkish children and their siblings in Southeastern Anatolia.
    Karaoglan M
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1311-1320. PubMed ID: 31693496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members.
    Bidet M; Bellanné-Chantelot C; Galand-Portier MB; Tardy V; Billaud L; Laborde K; Coussieu C; Morel Y; Vaury C; Golmard JL; Claustre A; Mornet E; Chakhtoura Z; Mowszowicz I; Bachelot A; Touraine P; Kuttenn F
    J Clin Endocrinol Metab; 2009 May; 94(5):1570-8. PubMed ID: 19208730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-classical congenital adrenal hyperplasia.
    Dacou-Voutetakis C; Dracopoulou M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():195-7. PubMed ID: 16641859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients.
    Dain LB; Buzzalino ND; Oneto A; Belli S; Stivel M; Pasqualini T; Minutolo C; Charreau EH; Alba LG
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):239-45. PubMed ID: 11874416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.
    Baş F; Kayserili H; Darendeliler F; Uyguner O; Günöz H; Yüksel Apak M; Atalar F; Bundak R; Wilson RC; New MI; Wollnik B; Saka N
    J Clin Res Pediatr Endocrinol; 2009; 1(3):116-28. PubMed ID: 21274396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.
    Marino R; Ramirez P; Galeano J; Perez Garrido N; Rocco C; Ciaccio M; Warman DM; Guercio G; Chaler E; Maceiras M; Bergadá I; Gryngarten M; Balbi V; Pardes E; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):427-35. PubMed ID: 21609351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
    Liao XY; Zhang YF; Gu XF
    Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
    Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
    Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia.
    Silveira EL; Elnecave RH; dos Santos EP; Moura V; Pinto EM; van der Linden Nader I; Mendonca BB; Bachega TA
    Clin Genet; 2009 Dec; 76(6):503-10. PubMed ID: 19930153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia.
    Neocleous V; Ioannou YS; Bartsota M; Costi C; Skordis N; Phylactou LA
    Clin Biochem; 2009 Sep; 42(13-14):1363-7. PubMed ID: 19501079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Saho R; Dolzan V; Zerjav Tansek M; Pastorakova A; Petrovic R; Knapkova M; Trebusak Podkrajsek K; Suput Omladic J; Bertok S; Avbelj Stefanija M; Kotnik P; Battelino T; Pribilincova Z; Groselj U
    Front Endocrinol (Lausanne); 2023; 14():1134133. PubMed ID: 37008950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.
    Xu C; Jia W; Cheng X; Ying H; Chen J; Xu J; Guan Q; Zhou X; Zheng D; Li G; Zhao J
    Mol Genet Genomic Med; 2019 Jun; 7(6):e671. PubMed ID: 30968594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.